Internal Medicine, Hematology & Oncology · Riverhead, NY
NPI
1306058581
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
750 Old Country Road Building 2
Riverhead, NY, 11901
Phone (631) 751-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.5M
273,664 services
Medicare patients, 2024
1,838
Average age 76
Drug cost, 2024
$12.3M
2,768 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Deepali Sharma was code J1439 (injection, ferric carboxymaltose, 1 mg), 113,250 times for 110 patients. In total Deepali Sharma billed 273,664 services in 273 codes, and Medicare paid $3.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-02-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 113,250 | 110 | $0.87 | $99K |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 31,800 | 30 | $2.27 | $72K |
| J0897 Injection, denosumab, 1 mg | Office | 8,460 | 84 | $20.39 | $173K |
| J1756 Injection, iron sucrose, 1 mg | Office | 6,800 | 23 | $0.17 | $1,140 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 6,603 | 21 | $44.70 | $295K |
| J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 5,660 | 12 | $36.98 | $209K |
| J9267 Injection, paclitaxel, 1 mg | Office | 4,180 | 11 | $0.08 | $332 |
| 36415 Venipuncture Blood Collection | Office | 3,407 | 1,523 | $8.62 | $29K |
| 85025 Blood Count | Office | 3,222 | 1,419 | $7.60 | $24K |
| 88185 Surgical Pathology Examination | Office | 3,166 | 133 | $22.21 | $70K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,778 | 110 | $0.09 | $244 |
| 80053 Clinical Chemistry | Office | 2,395 | 1,278 | $10.34 | $25K |
| 84100 Clinical Chemistry | Office | 1,573 | 887 | $4.64 | $7,306 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 1,514 | 338 | $52.19 | $79K |
| 83735 Clinical Chemistry | Office | 1,448 | 825 | $6.56 | $9,501 |
By year: 2022 $6.6M for 552,247 services; 2023 $4.2M for 337,180 services; 2024 $3.5M for 273,664 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 3,407 | 1,523 | $8.62 | $29K |
| 85025 Blood Count | 3,222 | 1,419 | $7.60 | $24K |
| 88185 Surgical Pathology Examination | 3,166 | 133 | $22.21 | $70K |
| 80053 Clinical Chemistry | 2,395 | 1,278 | $10.34 | $25K |
| 84100 Clinical Chemistry | 1,573 | 887 | $4.64 | $7,306 |
| 83735 Clinical Chemistry | 1,448 | 825 | $6.56 | $9,501 |
| 84550 Clinical Chemistry | 1,386 | 801 | $4.42 | $6,132 |
| 83615 Clinical Chemistry | 1,370 | 804 | $5.91 | $8,099 |
| 82728 Clinical Chemistry | 1,167 | 775 | $13.34 | $16K |
| 82784 Immunoassay | 864 | 194 | $9.11 | $7,874 |
Medicare prescription drug claims, 2024
In 2024, the drug Deepali Sharma prescribed most often to Medicare patients was Aranesp (Darbepoetin Alfa In Polysorbat), with 367 prescriptions and refills. In total Deepali Sharma wrote 2,768 Medicare prescriptions that cost $12.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Aranesp Darbepoetin Alfa In Polysorbat | 367 | 369 | 85 | $1.3M |
| Akynzeo Fosnetupitant/Palonosetron | 118 | 118 | 29 | $132K |
| Eliquis Apixaban | 112 | 181 | 30 | $105K |
| Anastrozole Generic | 106 | 239 | 31 | $1,436 |
| Xgeva Denosumab | 105 | 105 | 19 | $332K |
| Exemestane Generic | 83 | 169 | 23 | $11K |
| Octagam Immun Globg(Igg)/Malt/Iga Ov50 | 76 | 76 | Under 11 | $668K |
| Hydroxyurea Generic | 72 | 137 | 19 | $2,045 |
| Imbruvica Ibrutinib | 66 | 66 | Under 11 | $1.1M |
| Procrit Epoetin Alfa | 56 | 56 | 13 | $130K |
| Ibrance Palbociclib | 55 | 55 | Under 11 | $864K |
| Darzalex Faspro Daratumumab-Hyaluronidase-Fihj | 53 | 53 | Under 11 | $590K |
| Ondansetron Odt Ondansetron | 53 | 53 | 31 | $864 |
| Neulasta Onpro Pegfilgrastim | 49 | 49 | 12 | $314K |
| Gabapentin Generic | 49 | 63 | 14 | $562 |
Brand drugs: 1,755 claims; generic drugs: 1,013 claims; opioid claims: 21.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Deepali Sharma were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.